Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01196208
Title A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001
Recruitment No longer available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Seattle Genetics, Inc.

primary cutaneous T-cell non-Hodgkin lymphoma

Hodgkin's lymphoma

anaplastic large cell lymphoma


Brentuximab vedotin

Age Groups: senior | adult | child
Covered Countries USA | ITA | FRA | ESP | DEU | BEL

No variant requirements are available.